In Brief: Summit Technology/Visx
This article was originally published in The Gray Sheet
Executive Summary
Summit Technology/Visx: Ophthalmic laser firms reach settlement of "all outstanding U.S. and international patent infringement disputes between them, including the infringement litigation in Delaware related to Summit's Azema patent and in Canada related to Visx's L'Esperance patents," the firms state. Under the terms of the agreement, the companies cross-license each other's foreign patents; in the U.S., Summit's Azema patent is contributed to Pillar Point Partners, a joint venture formed in 1992 to hold U.S. eye laser patents. An exchange of payments under the pact will result in a net $4.5 mil. payment to Summit...